- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 03.01. | CareMax, Inc. - 8-K, Current Report | - | SEC Filings | ||
| CAREMAX Aktie jetzt für 0€ handeln | |||||
| 26.12.24 | CareMax, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 25.11.24 | ClareMedica Health Partners To Buy CareMax's Core Centers' Assets | 3 | RTTNews | ||
| 25.11.24 | CareMax looks to sell core centers' assets to ClareMedica | 4 | Seeking Alpha | ||
| 25.11.24 | CareMax, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 18.11.24 | Medical Center Operator CareMax Files For Chapter 11 Bankruptcy: Details | 1 | Benzinga.com | ||
| 18.11.24 | CareMax, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 18.11.24 | CareMax Files For Chapter 11 Bankruptcy Protection | - | RTTNews | ||
| 18.11.24 | CareMax Reaches Agreements to Sell Management Services Organization and Core Centers' Assets | 112 | Business Wire | MIAMI--(BUSINESS WIRE)--CareMax, Inc. (NASDAQ: CMAX; CMAXW) ("CareMax" or the "Company"), a leading technology-enabled value-based care delivery system, today announced it has entered into an agreement... ► Artikel lesen | |
| 17.11.24 | Caremax files for chapter 11 bankruptcy protection: reports | 2 | Seeking Alpha | ||
| 17.11.24 | CareMax Becomes Latest Health System to File for Bankruptcy | 2 | BNN Bloomberg | ||
| 13.11.24 | CareMax, Inc. - NT 10-Q, Notification of inability to timely file Form 10-Q or 10-QSB | - | SEC Filings | ||
| 04.11.24 | CareMax extends waiver on credit agreement defaults | 1 | Investing.com | ||
| 04.11.24 | CareMax, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 28.10.24 | CareMax extends waiver on credit agreement defaults | 1 | Investing.com | ||
| 28.10.24 | CareMax, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 21.10.24 | CareMax nimmt 5 Millionen US-Dollar Kredit auf | 1 | Investing.com Deutsch | ||
| 21.10.24 | CareMax draws $5 million under loan amid financial strain | 2 | Investing.com | ||
| 15.10.24 | CareMax secures extension on credit agreement waiver | 1 | Investing.com | ||
| 15.10.24 | CareMax, Inc. - 8-K, Current Report | - | SEC Filings |
Seite:
1 2 3 Weiter >>
41 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| INTUITIVE SURGICAL | 557,50 | +0,18 % | Opening Bell: Bitcoin, Gold, Novo Nordisk, Oracle, Meta, Alphabet, Intuitive Surgical, Boeing | Per Videoschalte umriss Donald Trump gestern beim Wirtschaftstreffen in Davos sein Wirtschaftsprogramm. Dies sorgte für gute Stimmung an der Börse. Der Dow Jones legte 0,92 Prozent zu, der Nasdaq 100... ► Artikel lesen | |
| ROKU | 77,46 | +0,06 % | Can Roku Channel Keep Pace in the Streaming Wars? Its Head of Content Thinks So | ||
| ATOSSA THERAPEUTICS | 0,909 | +2,94 % | Atossa Therapeutics, Inc.: Atossa Therapeutics Issues Letter to Shareholders Highlighting 2024 Accomplishments and Outlook for 2025 | SEATTLE, Jan. 23, 2025 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) ("Atossa" or the "Company"), a clinical-stage biopharmaceutical company dedicated to the prevention and treatment... ► Artikel lesen | |
| EVOFEM BIOSCIENCES | - | - | Evofem Biosciences, Inc.: Evofem Biosciences Announces Financial Results for the Third Quarter of 2024 | - Improved loss from operations by 31% -
- Acquired SOLOSEC, a commercially attractive, single-dose oral antibiotic FDA-approved to treat two pervasive sexual health... ► Artikel lesen | |
| QUIDELORTHO | 42,600 | +0,95 % | QuidelOrtho Announces Preliminary Unaudited Revenue for Fourth Quarter 2024 | SAN DIEGO--(BUSINESS WIRE)--QuidelOrtho Corporation (Nasdaq: QDEL) (the "Company" or "QuidelOrtho"), a global provider of innovative in vitro diagnostic technologies designed for point-of-care... ► Artikel lesen | |
| TEMPEST THERAPEUTICS | 0,906 | -0,33 % | Tempest Therapeutics: Tempest Receives Orphan Drug Designation from the U.S. Food and Drug Administration for Amezalpat to Treat Patients with Hepatocellular Carcinoma (HCC) | BRISBANE, Calif., Jan. 06, 2025 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company developing first-in-class1 targeted and immune-mediated therapeutics... ► Artikel lesen | |
| CENTENE | 61,33 | -0,32 % | Greenlight Capital Added Centene (CNC) on Dip | ||
| VERU | 1,124 | -9,86 % | Stock Traders Purchase Large Volume of Veru Call Options (NASDAQ:VERU) | ||
| NANO-X IMAGING | 8,240 | -5,83 % | Nano-X Imaging LTD.: Nanox.ARC Imaging System Receives FDA Clearance for General Use, Including Pulmonary Indication | Nanox.ARC receives additional FDA clearance to produce tomographic images for general use, including pulmonary, intra-abdominal and paranasal indications, in addition to its previously cleared indication... ► Artikel lesen | |
| FULGENT GENETICS | 16,500 | 0,00 % | Fulgent Reports Third Quarter 2024 Financial Results | EL MONTE, Calif.--(BUSINESS WIRE)--Fulgent Genetics, Inc. (NASDAQ: FLGT) ("Fulgent," or the "Company"), a technology-based company with a well-established laboratory services business and a therapeutic... ► Artikel lesen | |
| LANTHEUS | 93,36 | +0,43 % | Radiopharm Theranostics: Radiopharm Announces Strategic Co-Development Partnership with Lantheus for Australia | RAD to advance the clinical development of Lantheus innovative radiopharmaceuticals in Australia Initial collaboration will focus on a Phase 1 imaging trialFinancial incentives to be paid to RAD upon... ► Artikel lesen | |
| PERSPECTIVE THERAPEUTICS | 3,800 | -0,52 % | Perspective Therapeutics, Inc.: Perspective Therapeutics Continues to Pursue Dose Escalation of [212Pb]VMT-a-NET in its Ongoing Phase 1/2a Clinical Trial Based on Updated Interim Data Presented at the 2025 ASCO Gastrointestinal ... | Updated interim results with an additional 10 weeks of follow-up on the nine patients in Cohorts 1 (2.5 mCi) and Cohort 2 (5.0 mCi) of the ongoing Phase 1/2a study support continuation of dose-finding... ► Artikel lesen | |
| AMN HEALTHCARE SERVICES | 25,400 | -0,78 % | AMN Healthcare Services Inc. Q3 Profit Decreases, But Beats Estimates | WASHINGTON (dpa-AFX) - AMN Healthcare Services Inc. (AMN) reported earnings for third quarter that decreased from the same period last year but beat the Street estimates.The company's bottom... ► Artikel lesen | |
| OMNICELL | 40,400 | -2,88 % | Omnicell Announces Third Quarter 2024 Results | FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell, Inc. (NASDAQ:OMCL) ("Omnicell," "we," "our," "us," "management," or the "Company"), a leader in transforming the pharmacy care delivery model, today... ► Artikel lesen | |
| ALPHATEC | 10,900 | +0,93 % | Alphatec (NASDAQ:ATEC) Price Target Raised to $21.00 at Barclays |
Das Unternehmen CAREMAX INC kann der Branche Gesundheitswesen zugeordnet werden. Die relative Kursveränderung beträgt aktuell +6,71 % bei einem Aktienkurs von 0,450 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu CAREMAX INC finden Sie auf Wallstreet Online.
